Hasnyálmirigyrák: vizsgálatok itt: Kína
326 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleIRE After Chemotherapy for Locally Advanced Pancreatic Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07799935 - 1/2. fázisNot yet taking people in KínaA Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 80
- Run by
- Zhejiang University
See details and how to joinNCT07736612 - No phaseNot yet taking people in KínaBaduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 96
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07791550 - 1. fázisTaking peopleA Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
- Where
- Beijing, Chengdu, Hangzhou, Jinan, Nanchang, Tianjin
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05262491 - 1/2. fázisTaking peopleStudy of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
- Where
- Beijing, Changsha, Hangzhou, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 80
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT07640295 - 2. fázisTaking peopleAn Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06938282 - Korai 1. fázisTaking peopleA IIT Study of 177Lu-DOTA-SNA040
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- SmartNuclide Biopharma
See details and how to joinNCT07595237 - 1/2. fázisNot yet taking people in KínaJDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- West China Hospital
See details and how to joinNCT07175389 - 3. fázisTaking peoplePhase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 320
- Run by
- Genfleet Therapeutics (Shanghai) Inc.
See details and how to joinNCT07262567 - 1/2. fázisTaking peoplePhase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Hohhot, Jinan, Linyi, Shanghai, Shenyang, Shenzhen, Wuhan, Xiamen, Zhengzhou
- Életkor
- 18 év and over
- People
- 240
- Run by
- Allist Pharmaceuticals, Inc.
See details and how to joinNCT05288205 - 1. fázisTaking peopleA Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Where
- Beijing, Changsha, Chongqing, Heilongjiang, Shandong, Shanghai, Wuhan, Zhejiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- ArriVent BioPharma, Inc.
See details and how to joinNCT07066657 - No phaseNot yet taking people in KínaRisk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs
- Where
- Jinan
- Életkor
- 18 év to 85 év
- People
- 600
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07136701 - 1. fázisTaking peopleYMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07763301 - 2. fázisTaking peopleA Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07438106 - Korai 1. fázisTaking peopleA Study of GC203 TIL in PDCA (RJ)
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 10
- Run by
- Shanghai Juncell Therapeutics
See details and how to joinNCT06828328 - 2. fázisNot yet taking people in KínaSafety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT07745790 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Beijing, Chongqing, Jinan
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 2. fázisTaking peopleA Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
- Where
- Beijing, Changchun, Chengdu, Dalian, Guangzhou, Hangzhou, Jinan, Kunming, Nanchang, Nanning, Shanghai, Shenyang, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07255404 - 1. fázisTaking peopleStudy of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 493
- Run by
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07589205 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Guangzhou, Jinan, Shanghai
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 3. fázisTaking peopleAuricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
- Where
- Hangzhou
- Életkor
- 18 év to 85 év
- People
- 74
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07716228 - Korai 1. fázisTaking peopleA Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 10
- Run by
- Huashan Hospital
See details and how to joinNCT07707531 - 1. fázisNot yet taking people in KínaHSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 258
- Run by
- Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07699757 - 3. fázisTaking peopleSurufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 106
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07436741